NOD2/CARD15 mutations and presence of granulomas in pediatric and adult Crohn's disease

Inflammatory Bowel Diseases

Volumn 10, Issue 6, 2004, Pages 709-714

  Shaoul, Ron ^a   Karban, Amir ^b   Weiss, Batia ^b   Reif, Shimon ^c   Wasserman, Dror ^c   Pacht, Avi ^d   Eliakim, Rami ^b   Wardi, Joram ^e   Shirin, Haim ^g   Wine, Eitan ^f   Leshinsky Silver, Esther ^g   Levine, Arie ^f  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c Dana Medical Center   (Israel)

^d CARMEL MEDICAL CENTER   (Israel)

^e Molecular Genetics Laboratory   (Israel)

^f Pediatric Gastroenterology Unit   (Israel)

^g WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Child; Crohn's disease; Diagnosis; Granuloma; NOD2

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; GENOMIC DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; COLON BIOPSY; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DNA EXTRACTION; FEMALE; GASTROSCOPY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; GRANULOMA; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROHN DISEASE; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRANULOMA; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISRAEL; MALE; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS;

EID: 9144257379     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200411000-00003     Document Type: Article

References (37)

1. Kornbluth A, Sachar DB, Salomon P. Crohn's disease. In: Feldman M, Scharschmidt BF, Sleisenger MH, et al, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 6th ed. New York: WB Saunders; 1998:1708-1734.
2. Shepherd NA. Granulomas in the diagnosis of intestinal Crohn's disease: a myth exploded? Histopathology. 2002;41:166-168.
3. Kleer CG, Appelman HD. Surgical pathology of Crohn's disease. Surg Clin North Am. 2001;81:13-30.
4. Heimann TM, Miller F, Martinelli G, et al. Correlation of presence of granulomas with clinical and immunologic variables in Crohn's disease. Arch Surg. 1988;123:46-48.
5. Hugot JP, Zouali H, Lesage S, et al. Etiology of the inflammatory bowel diseases. Int J Colorectal Dis. 1999;14:2-9.
6. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
7. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411:599-603.
8. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606.
9. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet. 2001;357:1925-1928.
10. Bonen DK, Ogura Y, Nicolae DL, et al. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology. 2003;124:140-146.
11. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347: 417-429.
12. Sartor RB, Herfarth H, Van Tol EAF. Bacterial cell wall polymer-induced granulomatous inflammation. Methods. 1996;9:233-247.
13. Matsumoto T, Nakamura S, Jin-No Y, et al. Role of granuloma in the immunopathogenesis of Crohn's disease. Digestion. 2001;63:43-47.
14. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19-20.
15. Abroad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology. 2002;122: 854-866.
16. Ahmadian A, Gharizadeh B, Gustafsson AC, et al. Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem. 2000;280: 103-110.
17. Fidder HH, Olschwang S, Avidan B, et al. Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients. Am J Med Genet. 2003;121A:240-244.
18. Levine A, Karban A, Eliakim R, et al. Presence of single or multiple single nucleotide polymorphisms in the NOD2 and Toll like receptor 4 genes are not associated with pediatric onset of Crohn's disease. Gut. 2003; 52(suppl):A36.
19. Karban A, Waterman M, Panhuysen C, et al. Differences of NOD2 (CARD15) genotype and phenotype among Ashkenazi and Sephardic Jews with Crohn's disease: preliminary evidence indicating higher carrier rate in the Ashkenazi patients. Gastroenterology. 2003;124:A373.
20. Fuller CL, Flynn JL, Reinhart TA. In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis. Infect Immun. 2003;71:7023-7034.
21. Schmitz-Moormann P, Schag M. Histology of the lower intestinal tract in Crohn's disease of children and adolescents: Multicentric Paediatric Crohn's Disease Study. Pathol Res Pract. 1990;186:479-484.
22. Markowitz J, Kahn E, Daum F. Prognostic significance of epithelioid granulomas found in rectosigmoid biopsies at the initial presentation of pediatric Crohn's disease. J Pediatr Gastroenterol Nutr. 1989;9:182-186.
23. Morpurgo E, Petras R, Kimberling J, et al. Characterization and clinical behavior of Crohn's disease initially presenting predominantly as colitis. Dis Colon Rectum. 2003;46:918-924.
24. Chambers TJ, Morson BC. The granuloma in Crohn's disease. Gut. 1979; 20:269-274.
25. Wolfson DM, Sachar DB, Cohen A, et al. Granulomas do not affect postoperative recurrence rates in Crohn's disease. Gastroenterology. 1982;83: 405-409.
26. Bairead E, Harmon DL, Curtis AM, et al. Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet. 2003;11:237-244.
27. Abdullah BA, Gupta SK, Croffie JM, et al. The role of esophagogastroduodenoscopy in the initial evaluation of childhood inflammatory bowel disease: a 7-year study. J Pediatr Gastroenterol Nutr. 2002;35: 636-640.
28. Alcantara M, Rodriguez R, Potenciano JL, et al. Endoscopic and bioptic findings in the upper gastrointestinal tract in patients with Crohn's disease. Endoscopy. 1993;25:282-286.
29. Cameron DJ. Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn's disease: a prospective study. J Gastroenterol Hepatol. 1991;6:355-358.
30. Danzi JT, Farmer RG, Sullivan BH Jr, et al. Endoscopic features of gastroduodenal Crohn's disease. Gastroenterology. 1976;70:9-13.
31. Griffiths AM, Alemayehu E, Sherman P. Clinical features of gastroduodenal Crohn's disease in adolescents. J Pediatr Gastroenterol Nutr. 1989; 8:166-171.
32. Lenaerts C, Roy CC, Vaillancourt M, et al. High incidence of upper gastrointestinal tract involvement in children with Crohn disease. Pediatrics. 1989;83:777-781.
33. Mashako MN, Cezard JP, Navarro J, et al. Crohn's disease lesions in the upper gastrointestinal tract: correlation between clinical, radiological, endoscopic, and histological features in adolescents and children. J Pediatr Gastroenterol Nutr. 1989;8:442-446.
34. Oberhuber G, Hirsch M, Stolte M. High incidence of upper gastrointestinal tract involvement in Crohn's disease. Virchows Arch. 1998;432: 49-52.
35. Ruuska T, Vaajalahti P, Arajarvi P, et al. Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr. 1994;19:181-186.
36. Schmidt-Sommerfeld E, Kirschner BS, Stephens JK. Endoscopic and histologic findings in the upper gastrointestinal tract of children with Crohn's disease. J Pediatr Gastroenterol Nutr. 1990;11:448-454.
37. Witte AM, Veenendaal RA, Van Hogezand RA, et al. Crohn's disease of the upper gastrointestinal tract: the value of endoscopic examination. Scand J Gastroenterol Suppl. 1998;225:100-105.